F-group (family)
268.1.1.3 SCP2_2
Ligands and drugs
154
Member domains
79
with ligand contacts (≤ 4 Å)
51.3% of members
87
with DrugDomain annotations
56.5% of members
49
with a DrugBank compound
31.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 268.1.1.3 belongs to X-group 268 Sterol carrier protein-like, which binds 7.9 ligand superclasses per 20 proteins, broader than 54% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01421 | PAR | Paromomycin | 6 |
| DB00684 | TOY | Tobramycin | 2 |
| DB00450 | USS | Droperidol | 1 |
| DB00502 | GMJ | Haloperidol | 1 |
| DB00608 | CLQ | Chloroquine | 1 |
| DB00878 | XC9 | Chlorhexidine | 1 |
| DB01131 | XEW | Proguanil | 1 |
| DB02736 | ACM | Acetamide | 1 |
| DB05636 | YMZ | (+)-Mefloquine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 14 |
| CL | CHLORIDE ION | 13 |
| PAR | PAROMOMYCIN | 6 |
| P4K | polyethylene glycol | 5 |
| TOY | TOBRAMYCIN | 2 |
| 5LQ | 5-(3-chlorophenyl)-4-methyl-~{N}-(3-morpholin-4-ylpropyl)-1,1-bis(oxidanylidene)-1,2-thiazol-3-amine | 1 |
| 5LR | 5-(4-chlorophenyl)-~{N}-[3-(3,4-dihydro-1~{H}-isoquinolin-2-yl)propyl]-4-methyl-1,1-bis(oxidanylidene)-1,2-thiazol-3-amine | 1 |
| 6E9 | N-(3-methoxyphenyl)-N-methyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonamide | 1 |
| 7LF | 1-(4-fluorophenyl)-2-[2-(4-methylphenyl)-2-oxoethyl]pyrrolo[1,2-a]pyrazin-2-ium | 1 |
| ACO | ACETYL COENZYME *A | 1 |
| CJ7 | 8-fluoro-5-methyl-3-{[2-(piperidin-1-yl)ethyl]sulfanyl}-5H-[1,2,4]triazino[5,6-b]indole | 1 |
| CLQ | N4-(7-CHLORO-QUINOLIN-4-YL)-N1,N1-DIETHYL-PENTANE-1,4-DIAMINE | 1 |
| GMJ | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one | 1 |
| H66 | 2-{[(7S)-4-amino-7-ethyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}-N-[2-(piperidin-1-yl)ethyl]acetamide | 1 |
| MGmetal | MAGNESIUM ION | 1 |
| NRS | N-methyl-N-(naphthalen-2-yl)-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonamide | 1 |
| NRV | N,N-diethyl-2-[(8-fluoro-5-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]ethan-1-amine | 1 |
| NRY | 1-(4-fluorophenyl)-2-[2-(4-fluorophenyl)-2-oxoethyl]pyrrolo[1,2-a]pyrazin-2-ium | 1 |
| PV3 | 1-{2-[(3-chlorophenyl)methoxy]phenyl}-N-[(pyridin-4-yl)methyl]methanamine | 1 |
| PVF | 1-{3-[(4-chlorophenyl)methoxy]phenyl}methanamine | 1 |